[e-drug] FIP Global Pharmacy Workforce and Migration Report

e-drug
1

E-DRUG: FIP Global Pharmacy Workforce and Migration Report
----------------------------------------------------------
[Dealyed posting; please send messages to e-drug@healthnet.org and not to e-drug-owner@healthnet.org Thanks; Wilbert]

April 7, 2006: To coincide with the global recognition of World Health Day, FIP officially launches its Global Pharmacy Workforce and Migration Report – a Call for Action. The launch is a timely compliment to World Health Day, which this year focuses on the theme “Working Together for Health”, and which will see an effort from health stakeholders worldwide to raise awareness of the increasingly compromised situation surrounding the global health workforce.

Over the past year the FIP workforce and migration study has been a major focus of the Federation, and has involved the contribution of over 100 individuals from pharmacy professional and regulatory bodies, training institutions and Ministries of Health. The report, the first of its kind to profile workforce issues specifically related to the profession of pharmacy, provides a current overview of important issues affecting the pharmacy work force such as regulation and description, shortages, distribution imbalances, and Continuing Professional Development. With this report, FIP urges pharmacy professional and regulatory bodies, policy makers, pharmacy education providers, and pharmacists to actively document the profession and build an evidence base from which to access credible support for change, as well as develop national strategies to address workforce issues. It is hoped that with this data a precedent is set for government and professional bodies to dedicate contin uous attention to the issue.

This strategy holds true for the FIP as well, whose overall aim is to increase collaborative efforts with and amongst Member Organisations so that pharmacy workforce issues may be appropriately and effectively examined, and that future directions for all aspects of the profession may be mapped out. It is becoming increasingly accepted, opportunely, that the pharmacy profession has an essential and integral role within all aspects of healthcare on local, national, and global levels, and it is imperative that human resources continue to strengthen in order to meet the needs of the population and growing expectations of the profession.

FIP invites all to view the report at: www.fip.org/hr

Tana Wuliji, Pharmacist
Project Coordinator
International Pharmaceutical Federation (FIP)
PO Box 84200
2508AE Den Haag
The Netherlands
Phone: +31-70-302-1978
Mobile: +31-615634665
Fax: +31-70-3021999
Email: tana@fip.org
Website: http://www.fip.org

Meet your international colleagues in Salvador Bahia, Brazil!
FIP World Congress of Pharmacy and Pharmaceutical Sciences
25-31 August 2006
http://www.fip.org/brazil2006/

The International Pharmaceutical Federation (FIP) is the global federation of national organisations of pharmacists and pharmaceutical scientists dedicated to improving the access to and value of appropriate medicine use worldwide, and contributing to changes in science, practice and health policies worldwide.

2

E-DRUG: RFI: Formulary for a tertiary care hospital?
----------------------------------------------------

Dear colleagues

Kenyatta National Hospital is situated in Nairobi Kenya. It has the following key statistics:

- Bed capacity 1800 (Bed occupancy usually 2500 and above)
- Has 50 wards, 20 specialized out patient clinics, 24 theatres, 11 bi pharmacies and an accident and emergency department
- Daily out patient attendance: 2000

It serves as a regional referral hospital as well as a teaching hospital for medical and paramedical professionals up to PHD level

We have a major challenge in developing a formulary to cater for all these types of needs ranging from primary care to quaternary care as well as teaching/research

I would be grateful for anyone with an experience in developing and implementing a formulary for a similar type of hospital could share that experience with me.

Any advice is welcome!

Note: Our Medicines and Therapeutics Committee has just undergone some basic orientation training and is focussed on developing and implementing a formulary list/manual within the next one year

Dr Atieno Ojoo
Chief Pharmacist
Kenyatta National Hospital
Nairobi, Kenya

3

E-DRUG: RFI: Formulary for a tertiary care hospital? (2)
--------------------------------------------------------

Dear Atieno

You may wish to utilise the WHO Model Formulary http://mednet3.who.int/EMLib/wmf.aspx
developed by WHO with monographs for all essential medicines currently on the WHO's essential medicine list in collaboration with the editorial team of the British National Formulary (you will recognise the well-known BNF style in the Model Formulary).
   
You are free to copy as many sections, chapters from the WHO model formulary as you need and you can download the editable word files at http://mednet3.who.int/EMLib/wmf/English/wmfEnDetails.asp
   
With such copying/adaptation you can significantlly cut down your time, cost and efforts in producing your hospital formulary.

Regarding how to go about the adaptation and how to include additional useful local information, please see the short manual "How to develop a National formulary based on the WHO Model Formulary - A practical guide" provided at http://mednet3.who.int/EMLib/wmf.aspx
   
In case you have difficulty in downloading files you can request for a free CD + printed copy of the manual from modelformulary@who.int

regards,
   
Klara Tisocki

Dr Klara Tisocki B.Pharm., M.Sc., Ph.D.
Phone: +965 7975493
Fax: +1866-284-1909
e-mail: ktisocki@yahoo.ie, tisocki@hsc.edu.kw
Faculty of Pharmacy, Kuwait University
Kuwait

4

E-DRUG: RFI: Formulary for a tertiary care hospital? (3)
--------------------------------------------------------

Hallo,

The formulary list needs the in-put of the pharmacy and therapeutics committee of KNH. Organize these meetings weekly and discuss on what drugs to be put in your least; the drugs in that formulary should be cheap and effective. The key word here is cheap and effective. For success to be realized, the physicians must have access to what is in the formulary and only prescribe what is on that formulary.

However, there are exceptions to this: the physician may have a good reason for wanting to use a drug that is not on formulary - develop a form that has to be generated from the pharmacy to the physician, and the physician must explain why he cannot use anything in your formulary - make them accountable before you order for the drug that they are requesting.

Patients sometimes get admitted to the hospitals for acute illnesses, but remember that they may have been in some form of chronic treatment e.g. Diabetes, hypertension etc - let pharmacy be involved in making sure that a pharmacist identifies these medications before a pt uses them in hospital - physicians should also take note of these drugs and include them in pt MAR in order to avoid interaction with foods and other drugs.

Most important thing is that the formulary you develop must come from the in-put of pharmacists, physicians, nurses and hospital administrators. Key words for developing countries: cheap and effective.

Thanks

Dr. Otieno Aduma
otienoaduma@hotmail.com

5

E-DRUG: RFI: Formulary for a tertiary care hospital? (4)
--------------------------------------------------------

Hi Atieno,

You may also wanna check out www.formularyproduction.com
Most teaching hospitals in the US also have their formularies posted on the
web. Check and compare.

Dr Otieno
USA
otienoaduma@hotmail.com

6

E-DRUG: Update on formulary for a tertiary care hospital
--------------------------------------------------------

Dear colleagues,

I would like to take this opportunity to thank all of you who contributed in any way towards my questions regarding development of a formulary for the 2000 bed Kenyatta National Hospital in Nairobi, Kenya.
   
I would like to inform you that the process, which is as important as the output, was very challenging, but a great learning opportunity for all. For example, we developed criteria and tools for application to add/delete medicines to the formulary list, but this was used for less than 50% of new drug applications. The formulary committee secretariat did a lot of reviews. We hope to publish details of the process together with key indicators and figures.
   
The formulary list (incorporating Vital, Essential and Non-formulary items) is now ready and has formed the basis for procurement of medicines for this year 2007.
   
We are working on the formulary manual to provide additional information useful in house processes for obtaining, use and managing medicines

regards

Dr Atieno Ojoo, BPharm, MPH
Chief Pharmacist
Kenyatta National Hospital
Nairobi, Kenya
atisojoo@yahoo.co.uk

[Can we see the list somewhere on a website? Wilbert, moderator]